False-negative fluorine-18-FDG PET in metastatic carcinoid.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9293792.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Carcinoid tumors have high numbers of somatostatin receptors that allow scintigraphic imaging with the radiolabeled somatostatin analog octreotide. Experience, however, with PET using 2-[18F]fluoro-2-deoxy-D-glucose (18FDG) in carcinoid is very limited. In two prior studies which investigated the utility of 18FDG-PET in cancer detection, three patients with small, solitary, indolent carcinoid tumors had false-negative results. We report a case where 18FDG-PET imaging was false-negative in a patient with known metastatic carcinoid and a positive octreotide scan.
Medical subject headings
- Carcinoid Tumor
- Deoxyglucose
- Fluorine Radioisotopes
- HIV Seropositivity
- Liver Neoplasms
- Radiopharmaceuticals
- Tomography, Emission-Computed